AusPAR: Meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine

Australian Public Assessment Report

AusPAR

AusPAR: Meningococcal (Groups A,C,W-135 and Y) oligosaccharide CRM197 conjugate vaccine [PDF, 1.51 MB]

AusPAR: Meningococcal (Groups A,C,W-135 and Y) oligosaccharide CRM197 conjugate vaccine [Word, 3.71 MB]

Attachment: Product Information: Meningococcal (Groups A,C,W-135 and Y) oligosaccharide CRM197 conjugate vaccine [PDF, 458.61 KB]

Attachment: Product Information: Meningococcal (Groups A,C,W-135 and Y) oligosaccharide CRM197 conjugate vaccine [Word, 163.29 KB]

Attachment: Extract from Clinical Evaluation Report: Meningococcal (Groups A,C,W-135 and Y) oligosaccharide CRM197 conjugate vaccine [PDF, 2.01 MB]

Attachment: Extract from Clinical Evaluation Report: Meningococcal (Groups A,C,W-135 and Y) oligosaccharide CRM197 conjugate vaccine [Word, 3.02 MB]

Device/Product Name

Menveo

Active ingredients

Meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine

AusPAR Date

10 April 2018

Published

13 April 2018

Submission Number

PM-2017-00536-1-2

Submission Type

Extension of indications

Decision

Approved